BrainAurora Medical Technology (HKG:6681) raised HK$501.3 million in net proceeds from its initial public offering in Hong Kong.
The cognitive impairment digital therapeutics developer offered 181,112,000 shares at HK$3.22 apiece, according to a Monday night filing.
The deal's Hong Kong or public offering portion was 11.39 times oversubscribed, with 18,112,000 shares on offer as originally planned.
The international or placing shares were 1.01 times subscribed, and the firm issued 163 million shares.
BrainAurora Medical Technology will make its trading debut on the Hong Kong bourse Wednesday, Jan. 8.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.